SEC Tracker
Get the app

Ionetix

Ionetix completes an acquisition or sale of assets

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Completes an acquisition or sale of assets (2.01)
  • Sells unregistered shares (3.02)
  • Changes shareholder rights (3.03)
  • Changes its auditor (4.01)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)
  • Changes its shell company status (5.06)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Ionetix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2835) and public float not reported.

  1. Burzynski Research Institute BZYR
  2. Anbio Biotechnology NNNN
  3. Nymox Pharmaceutical NYMXF
  4. Asep Medical Holdings SEPSF
  5. Trinity Biotech TRIB